Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1

American Journal of Tropical Medicine and Hygiene

Volumn 59, Issue 2, 1998, Pages 307-311

  Karanja, Diana M S ^a   Boyer, Anne E ^b   Strand, Mette ^d   Colley, Daniel G ^b   Nahlen, Bernard L ^a   Ouma, John H ^c   Secor, W Evan ^b  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c MINISTRY OF HEALTH   (Kenya)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; PARASITE ANTIGEN; PRAZIQUANTEL;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FECES ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; T LYMPHOCYTE SUBPOPULATION;

EID: 0031708371     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1998.59.307     Document Type: Article

References (19)

1. Harnett W, Kusel JR, 1986. Increased exposure of parasite antigens at the surface of adult male Schistosoma mansoni exposed to praziquantel in vitro. Parasitology 93: 401-405.
2. Modha J, Lambertucci JR, Doenhoff MJ, McLaren DJ, 1990. Immune dependence of schistosomicidal chemotherapy: an ultrastructural study of Schistosoma mansoni adult worms exposed to praziquantel and immune serum in vivo. Parasite Immunol 12: 321-334.
3. Sabah AA, Fletcher C, Webbe G, Doenhoff MJ, 1985. Schistosoma mansoni: reduced efficacy of chemotherapy in infected T-cell-deprived mice. Exp Parasitol 60: 348-354.
4. Sturrock RF, Doenhoff MJ, Webbe G, 1986. Schistosomiasis. Zande MA Zak O, eds. Experimental Models in Antimicrobial Chemotherapy. Volume 3. San Francisco, CA: Academic Press, 241-279.
5. Karanja DMS, Colley DG, Nahlen BL, Ouma JH, Secor WE, 1997 Studies on schistosomiasis in western Kenya: I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections. Am J Trop Med Hyg 56: 515-521.
6. Barsoum IS, Kamal KA, Bassily S, Deelder AM, Colley DG, 1991. Diagnosis of human schistosomiasis by detection of circulating cathodic antigen with a monoclonal antibody. J Infect Dis 164: 1010-1013.
7. Tsang VCW, Peralta JM, Simons AR, 1983. Enzyme-linked immunoelectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis. Methods Enzymol 92: 377-391.
8. Tanaka Hall TM, Joseph GT, Strand M, 1995. Schistosoma mansoni: molecular cloning and sequencing of the 200-kDa chemotherapeutic target antigen. Exp Parasitol 80: 242-249.
9. Brindley PJ, Sher A, 1987. The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response. J Immunol 139: 215-220.
10. Brindley PJ, Strand M, Norden AP, Sher A, 1989. Role of host antibody in the chemotherapeutic action of praziquantel against Schistosoma mansoni: identification of target antigens. Mol Biochem Parasitol 34: 99-108.
11. Doenhoff MJ, Hassounah OA, Lucas SB, 1985. Does the immunopathology induced by schistosome eggs potentiate parasite survival? Immunol Today 6: 203-206.
12. Doenhoff MJ, Hassounah O, Murare H, Bain J, Lucas S, 1986. The schistosome egg granuloma: immunopathology in the cause of host protection or parasite survival? Trans R Soc Med Hvg 80: 503-514.
13. Doenhoff MJ, Sabah AA, Fletcher C, Webbe G, Bain J, 1987. Evidence for immune-dependent action of praziquantel on Schistosoma mansoni in mice. Trans R Soc Trop Med Hyg 81: 947-951.
14. Doenhoff MJ, Modha J, Lambertucci JR, 1988. Anti-schistosome chemotherapy enhanced by antibodies specific for a parasite esterase. Immunology 65: 507-510.
15. Wang Y, Ardestani SK, Liang B, Beckham C, Watson RR, 1994. Anti-IL-4 monoclonal antibody and IFN-γ administration retards development of immune dysfunction and cytokine dysregulation during murine AIDS. Immunology 83: 384-389.
16. Maggi E, Mazzetti M, Ravina A, Annunziato F, De Carli M, Piccinni MP, Manetti R, Carbonari M, Pesce AM, Del Prete G, Romagnani S, 1994. Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 265: 244-248.
17. Williams ME, Montenegro S, Domingues AL, Wynn TA, leixeira K, Mahanty S, Coutinho A, Sher A, 1994. Leukocytes of patients with Schistosoma mansoni respond with a Tn2 pattern of cytokine to mitogen or egg antigens but with a Th0 pattern to worm antigens. J Infect Dis 170: 946-954.
18. Sabin EA, Araujo MI, Carvalho EM, Pearce EJ, 1996. Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. J Infect Dis 173: 269-272.
19. Bentwich Z, Kalinkovich A, Weisman Z, 1995. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 16: 187-191.